Circulating tumor cells in sarcomas: a brief review

Medical Oncology

Volumn 32, Issue 1, 2015, Pages 1-7

  Chang, Le ^a   Asatrian, Greg ^a   Dry, Sarah M ^a   James, Aaron W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circulating tumor cell; Ewing s sarcoma; RT PCR; Sarcoma detection; Translocation sarcoma

Indexed keywords

CELL SURFACE PROTEIN; COLLAGEN TYPE 1; VIMENTIN;

ADVANCED CANCER; ALVEOLAR SOFT PART SARCOMA; BLOOD; BONE MARROW; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CELL SURFACE; CIRCULATING TUMOR CELL; EPITHELIOID SARCOMA; EWING SARCOMA; FLOW CYTOMETRY; FUSION GENE; GENE FUSION; HUMAN; INTERMEDIATE FILAMENT; LIPOSARCOMA; MORBIDITY; NEUROBLASTOMA; NEUROECTODERM TUMOR; OSTEOSARCOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; PATHOLOGY; TUMOR EMBOLISM;

HUMANS; NEOPLASTIC CELLS, CIRCULATING; SARCOMA;

EID: 84920159736     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0430-9     Document Type: Review

References (38)

1. National Institute of Cancer. A snapshot of sarcoma. 2013. http://www.cancer.gov/researchandfunding/snapshots/pdf/Sarcoma-Snapshot.pdf. Accessed 20 Nov 2014.
2. Leung CT, Brugge JS. Tumor self-seeding: bidirectional flow of tumor cells. Cell. 2009;139(7):1226–8.
3. Sieuwerts AM, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst. 2009;101(1):61–6.
4. Allard WJ, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897–904.
5. Hou JM, et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol. 2009;175(2):808–16.
6. Hayes DF, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res. 2006;12(14 Pt 1):4218–24.
7. Cristofanilli M, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005;23(7):1420–30.
8. de Bono JS, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14(19):6302–9.
9. Cohen SJ, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009;20(7):1223–9.
10. Satelli A, et al. Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res. 2014;74(6):1645–50.
11. Wong IH, Chan AT, Johnson PJ. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study. Clin Cancer Res. 2000;6(6):2183–8.
12. Burchill SA, et al. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol. 2001;19(6):1795–801.
13. Hofman VJ, et al. Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol. 2011;135(1):146–56.
14. Avigad S, et al. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer. 2004;100(5):1053–8.
15. Schleiermacher G, et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor. J Clin Oncol. 2003;21(1):85–91.
16. Peter M, et al. Sensitive detection of occult Ewing’s cells by the reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995;72(1):96–100.
17. Fagnou C, et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing’s tumor. Société Française d’Oncologie Pédiatrique. J Clin Oncol. 1998;16(5):1707–11.
18. Zoubek A, et al. Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation. Int J Cancer. 1998;79(1):56–60.
19. Thomson B, et al. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing’s sarcoma and alveolar rhabdomyosarcoma. Bone Marrow Transplant. 1999;24(5):527–33.
20. Delattre O, et al. The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331(5):294–9.
21. West DC, et al. Detection of circulating tumor cells in patients with Ewing’s sarcoma and peripheral primitive neuroectodermal tumor. J Clin Oncol. 1997;15(2):583–8.
22. Pfleiderer C, et al. Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR. Int J Cancer. 1995;64(2):135–9.
23. Przybyl J, et al. Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications. Med Oncol. 2014;31(8):109.
24. de Alava E, et al. Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples. Diagn Mol Pathol. 1998;7(3):152–7.
25. Dubois SG, et al. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow. Pediatr Blood Cancer. 2010;54(1):13–8.
26. Hoshino M, et al. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma. Cancer Genet Cytogenet. 2009;190(2):75–80.
27. Hashimoto N, et al. Detection of SYT-SSX fusion gene in peripheral blood from a patient with synovial sarcoma. Am J Surg Pathol. 2001;25(3):406–10.
28. Kelly KM, Womer RB, Barr FG. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Cancer. 1996;78(6):1320–7.
29. Gallego S, et al. Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay. J Cancer Res Clin Oncol. 2006;132(6):356–62.
30. Shirahata A, et al. Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res. 2009;29(1):279–81.
31. Kitamura YH, et al. Frequent methylation of vimentin in well-differentiated gastric carcinoma. Anticancer Res. 2009;29(6):2227–9.
32. Gilles C, et al. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003;63(10):2658–64.
33. Meis JM, Ordóñez NG, Gallager HS. Sarcomatoid carcinoma of the breast: an immunohistochemical study of six cases. Virchows Arch Pathol Anat Histopathol. 1987;410(5):415–21.
34. Eckert F, de Viragh PA, Schmid U. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors. J Cutan Pathol. 1994;21(2):140–50.
35. Li M, et al. A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis. J Exp Clin Cancer Res. 2010;29:109.
36. Hatano H, et al. A PCR-ELISA assay for the detection of disseminated osteosarcoma cells in a mouse metastatic model. J Orthop Sci. 2001;6(3):269–75.
37. Chinen LT, et al. Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion. Onco Targ Ther. 2014;7:1609–17.
38. Goldblum, JR, Weiss SW, Folpe, AL. Enzinger and weiss’s soft tissue tumors, 6th ed. Philadelphia: Elsevier; 2008.